Aldebaran Capital’s Pliant Therapeutics PLRX Stock Holding History

Aldebaran Capital’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$436K	Buy	+403,381	New	+$447K	0.31%	33

Other funds holding PLRX

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return

Prosight Management Dallas, Texas $515M AUM 2.95% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

Marshall Wace London, United Kingdom $114B AUM 35.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Aldebaran Capital's PLRX Position: Q3 2026 in Review

Aldebaran Capital opened a new position in Pliant Therapeutics (PLRX) in Q3 2026: 403,381 shares worth $436K. The stake represents 0.31% of the portfolio and ranks #33 among its holdings.

49 funds tracked by Wall St. Rank hold PLRX as of Q3 2026.

Aldebaran Capital held 403,381 shares of Pliant Therapeutics worth $436K as of Q3 2026.
Pliant Therapeutics was a new Aldebaran Capital position in Q3 2026.
Pliant Therapeutics made up 0.31% of Aldebaran Capital's portfolio in Q3 2026, its #33 holding.
49 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2026.

Based on Aldebaran Capital's 13F filing for Q3 2026, filed 13 Nov 2026.